Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
SOMERSET, N.J., March 11, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced that its e-prescribing tool has been awarded the prestigious 2015 White Coat of Quality by Surescripts for clinical quality excellence in e-prescribing.
This award, which MTBC has achieved three times, bolsters its e-prescribing products and highlights its commitment to continue to train its users. “MTBC is pleased to have been awarded this recognition by Surescripts,” said Hadi Chaudhry, MTBC Chief Information Officer. He added, “MTBC’s development team is devoted to building quality solutions that assist providers in their practice and this recognition is evidence of that commitment.”
This achievement recognizes MTBC for upholding the highest standards of prescription content quality in e-prescribing. In addition, this year MTBC released its pioneering electronic prescribing Smartwatch app for Apple Watch users. Including this new app, MTBC now has over seven other mHealth apps in its suite. One of the most popular apps continues to be the MTBC ICD-10 converter app, which has consistently been the converter app of choice for providers across the nation, available for both Android and Apple devices.
To learn more about MTBC, please visit www.mtbc.com.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC [email protected] (732) 873-5133 x 141
